its corresponding negative control (shctrl) (Vigene Biosciences)
Structured Review
Its Corresponding Negative Control (Shctrl), supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+shctrl/negative+control+shrna/pm37807064-187-20-25
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: GADD45A regulates subcutaneous fat deposition and lipid metabolism by interacting with Stat1 Article Snippet: Control-adenovirus (Ctrl), mouse or porcine Gadd45a-overexpressing adenovirus (G45a-oe), mouse or porcine lentiviral shRNA targeting Gadd45a ( Article Title: GADD45A regulates subcutaneous fat deposition and lipid metabolism by interacting with Stat1. Article Snippet: shRNA:Article Title: Tideglusib suppresses stem-cell-like features and progression of osteosarcoma by inhibiting GSK-3β/NOTCH1 signaling. Article Snippet: Osteosarcoma is the most common primary bone tumor in children, teenagers and adolescents.. Cancer stem cells (CSCs) have the function to self-renew and keep the phenotype of tumor, causing clinical treatment failure.. Therefore, developing effective therapies to inhibit osteosarcoma progression is urgently necessary. Negative Control:Article Title: Tideglusib suppresses stem-cell-like features and progression of osteosarcoma by inhibiting GSK-3β/NOTCH1 signaling. Article Snippet: Osteosarcoma is the most common primary bone tumor in children, teenagers and adolescents.. Cancer stem cells (CSCs) have the function to self-renew and keep the phenotype of tumor, causing clinical treatment failure.. Therefore, developing effective therapies to inhibit osteosarcoma progression is urgently necessary. Synthesized:Article Title: Tideglusib suppresses stem-cell-like features and progression of osteosarcoma by inhibiting GSK-3β/NOTCH1 signaling. Article Snippet: Osteosarcoma is the most common primary bone tumor in children, teenagers and adolescents.. Cancer stem cells (CSCs) have the function to self-renew and keep the phenotype of tumor, causing clinical treatment failure.. Therefore, developing effective therapies to inhibit osteosarcoma progression is urgently necessary. |

